CLINICAL_TRIALS
trial_result
· 2024-08-15
Clinical Trial Update: SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363) [Phase 3]
Summary
A Phase 3 trial evaluating Singulair (montelukast) as a complementary therapy for asthma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Asthma | Phase 3 | Status: COMPLETED